About
Optilume is a medical technology company focused on developing innovative, minimally invasive treatments for male urinary tract conditions, specifically urethral strictures and benign prostatic hyperplasia (BPH). The company's flagship product, the Optilume® drug-coated balloon system, utilizes a proprietary paclitaxel-coated balloon technology. This system provides a durable and cost-effective alternative to traditional endoscopic and surgical treatments. The Optilume system works by inserting a balloon catheter into the urethra, which expands to mechanically dilate the stricture or prostate obstruction while delivering paclitaxel. This drug helps prevent tissue re-fusion during healing, leading to reduced recurrence rates and improved urinary flow. The treatment is performed using a telescopic camera, offering rapid symptom relief with a favorable safety profile. Optilume is headquartered in Minnesota, USA, and is owned by Laborie, a global medical technology company.
Technologies
Keywords
Company Information
-
Employees 14
-
Founded 2015
-
Total Funding $20000000
Location
Portsmouth, New Hampshire, United States, 03801